Edvardas Danila

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Borisov Se, Edvardas Danila, Andrei Maryandyshev et al. · European Respiratory Journal · 2019 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis

Edvardas Danila, Jolita Norkūnienė, Laimutė Jurgauskienė et al. · The Clinical Respiratory Journal · 2009 · 56 citations

Medicine, Immunology, Pathology +17

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Onno W. Akkerman, Alena Aleksa, Jan‐Willem C. Alffenaar et al. · International Journal of Infectious Diseases · 2019 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

S Koirala, Borisov Se, Edvardas Danila et al. · Pulmonology · 2021 · 47 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Relationship between radiologic patterns, pulmonary function values and bronchoalveolar lavage fluid cells in newly diagnosed sarcoidosis

Regina Aleksonienė, Ingrida Zeleckienė, Mindaugas Matačiūnas et al. · Journal of Thoracic Disease · 2017 · 42 citations · Full text

Medicine, Internal Medicine, Radiology +17